Ami Organics Ltd IPO- 1st September, 2021

Ami Organics Ltd IPO- 1st September, 2021

Company Background

Ami Organics Ltd. is one of the leading research  and development of speciality chemicals with varied end usage. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (API). It also manufactures key starting materials  for agrochemical and fine chemicals. The company is committed to the health care industry by supporting the development and commercialization of pharmaceutical intermediate products.

Business Information

 Company has a large pool of scientists and engineers who have the potential to drive Ami Organics Limited ahead to a higher level, It caters to domestic and certain multi-national pharmaceutical companies which cater to the large and fast-growing markets of Europe, China, Japan, Israel, UK, Latin America and the USA. Company products have been supplied to 25 countries and have long standing relationships with numerous domestic and global pharmaceutical companies. Specifically, to the large geographies of Italy, Finland, France and China with our manufacturing unit-1 located in Surat, unit-2 located in Ankleshwar, and unit-3 located in Jhagadia, Gujarat, India.The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.

Facts about the company
  • Ami Organics is likely to gain from high entry barriers in the pharma intermediates industry. Compliance requirements are stringent and in this area, the company has built solid entry barriers since it takes a long time to get enlisted as an API supplier
  • Dependency on certain therapeutic areas for deriving a significant portion of its revenue
  • Foreign exchange risks since the company is exports products to around 25 countries
  • Shortfall in the supply of its raw materials or an increase in the raw material cost may adversely affect the pricing and supply of its products.
 Points to note before investing in Ami Organics Ltd IPO
  • Leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban
  • Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas
  • Extensive geographical presence and diversified customer base
  • Strong R&D, sales and marketing capabilities
  • Consistent financial performance track record
  • High exntry barriers  in the chmical manufacturing industry in which the company operates.
 
Ami Organics Ltd IPO details

IPO Opening Date
September 1, 2021
IPO Closing Date
September 3, 2021
Issue Type
Book Built Issue IPO
Face Value
₹10 per equity share
IPO Price
₹603 to ₹610 per equity share
Market Lot
24 Shares
Min Order Quantity
24 Shares
Listing At
BSE, NSE
 
Allotment, Listing and Refunds details

Basis of Allotment Date
September 8, 2021
Initiation of Refunds
September 9, 2021
Credit of Shares to Demat Account
September 13, 2021
IPO Listing Date
September 14, 2021
 
Also Check: List of Upcoming IPOs in 2021
 
Know more-  www.5paisa.com/ipo
 
To apply from 5paisa Website- Apply IPO
 
To apply from 5paisa Mobile App- Apply IPO
 
We hope this information was helpful. For more details, you can post your queries below and we will be happy to share them with you.
 
Thank You!